The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
1d
HealthDay on MSNFDA Approves Susvimo for Diabetic Macular EdemaSusvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
1d
HealthDay on MSNFDA Approves Symbravo for Acute Treatment of Migraine in AdultsWEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results